Skip to main content

Articles

Page 67 of 76

  1. Cancer cells are known to secrete the stress molecules MICA and MICB that activate cytotoxicity by lymphocytes and NK cells through their NKG2D receptor as a mechanism of immunological defense. This work was u...

    Authors: Benny Weiss-Steider, Isabel Soto-Cruz, Christian A Martinez-Campos and Jorge Flavio Mendoza-Rincon
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:37
  2. Iodine 125 (125I) seed irradiation is an effective treatment for unresectable pancreatic cancers. However, the radiobiological mechanisms underlying brachytherapy remain unclear. Therefore, we investigated the in...

    Authors: Jian-xia Ma, Zhen-dong Jin, Pei-ren Si, Yan Liu, Zheng Lu, Hong-yu Wu, Xue Pan, Luo-wei Wang, Yan-fang Gong, Jun Gao and Li Zhao-shen
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:35
  3. Cancer cells have increased levels of transferrin receptor and lower levels of ferritin, an iron deficient phenotype that has led to the use of iron chelators to further deplete cells of iron and limit cancer ...

    Authors: Zhen Li, Hiroki Tanaka, Floyd Galiano and Jonathan Glass
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:34
  4. Various angiogenic regulators are involved in angiogenesis cascade. Transcription factor Ets-1 plays important role in angiogenesis, remodeling of extracellular matrix, and tumor metastasis. Ets-1 target genes...

    Authors: Zijing Lin, Yu Liu, Yuhui Sun and Xiuping He
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:31
  5. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) have been widely used for the treatment of non-small cell lung cancer (NSCLC). KRAS and EGFR somatic mutations in NSCLC may predict resistanc...

    Authors: Leina Sun, Qiang Zhang, Huanling Luan, Zhongli Zhan, Changli Wang and Baocun Sun
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:30
  6. Ovarian cancer remains the leading cause of death from gynaecological malignancy. More than 60% of the patients are presenting the disease in stage III or IV. In spite of combination of chemotherapy and surger...

    Authors: Caroline van Haaften, Colin C Duke, Arij M Weerheim, Nico PM Smit, Paul MM van Haard, Firouz Darroudi and Baptist JMZ Trimbos
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:29
  7. To elucidate whether rapamycin, the inhibitor of mTOR (mammalian target of rapamycin), can potentiate the cytotoxic effect of docetaxel in lung cancer cells and to probe the mechanism underlying such enhancement.

    Authors: Huiyan Niu, Jiahe Wang, Hui Li and Ping He
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:28
  8. To evaluate the expression of EGFR and COX-2 and their correlation with prognosis in NSCLC

    Authors: Feng Li, Yongmei Liu, Huijiao Chen, Dianying Liao, Yali Shen, Feng Xu and Jin Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:27

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2011 30:32

  9. Cyclooxygenase2 (COX-2), one isoform of cyclooxygenase proinflammatory enzymes, is responsible for tumor development, invasion and metastasis. Due to its role and frequent overexpression in a variety of human ...

    Authors: Qinghua Zhao, Chuan Wang, Jiaxue Zhu, Lei Wang, Shuanghai Dong, Guoqiao Zhang and Jiwei Tian
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:26
  10. As the expression of human sperm protein 17 (Sp17) in normal tissue is limited and the function is obscure, its aberrant expression in malignant tumors makes it to be a candidated molecular marker for tumor im...

    Authors: Fang-qiu Li, Shi-xin Zhang, Lian-xiao An and Yue-qing Gu
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:25
  11. The immune factors heat shock protein (HSP)/peptides (HSP/Ps) can induce both adaptive and innate immune responses. Treatment with HSP/Ps in cancer cell-bearing mice and cancer patients revealed antitumor immu...

    Authors: Quan-Yi Guo, Mei Yuan, Jiang Peng, Xue-Mei Cui, Ge Song, Xiang Sui and Shi-Bi Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:24
  12. Investigation of the expression of an intestinal stem cell marker in esophageal adenocarcinomas (EAC) with and without Barrett's Esophagus (BE), with respect to a cancer stem cell (CSC) hypothesis.

    Authors: Burkhard HA von Rahden, Stefan Kircher, Maria Lazariotou, Christoph Reiber, Luisa Stuermer, Christoph Otto, Christoph T Germer and Martin Grimm
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:23
  13. This study investigated the effects of Ulinastatin (UTI) and docataxel (Taxotere, TAX) on tumor growth and expression of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α) in breas...

    Authors: Xiaoliang Zhao, Xin Sun, Feng Gao, Jie Luo and Zhijun Sun
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:22
  14. Epidemiological studies propose that obesity increases the risk of several cancers, including melanoma. Obesity increases the expression of leptin, a multifunctional peptide produced predominantly by adipocyte...

    Authors: Fatemehsadat Amjadi, Shaghaygh Haghjooy Javanmard, Hamid Zarkesh-Esfahani, Majid Khazaei and Manijeh Narimani
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:21
  15. Recently, miR-451 as a tumor suppressor has been reported in other studies. However, whether miR-451 can affect the sensitivity of non-small cell lung cancer (NSCLC) cells to cisplatin (DDP) remains unclear. T...

    Authors: Hai-Bo Bian, Xuan Pan, Jin-Song Yang, Zhao-Xia Wang and Wei De
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:20
  16. Lung cancer is one of the most common human cancers and the leading cause of cancer death worldwide. The identification of lung cancer associated genes is essential for lung cancer diagnosis and treatment.

    Authors: Liangan Chen, Zhixin Liang, Qing Tian, Chunsun Li, Xiuqing Ma, Yu Zhang, Zhen Yang, Ping Wang and Yanqin Li
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:18
  17. Bostrycin is a novel compound isolated from marine fungi that inhibits proliferation of many cancer cells. However, the inhibitory effect of bostrycin on lung cancers has not been reported. This study is to in...

    Authors: Wei-Sheng Chen, Jun-Na Hou, Yu-Biao Guo, Hui-Ling Yang, Can-Mao Xie, Yong-Cheng Lin and Zhi-Gang She
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:17
  18. This retrospective analysis is focused on the efficacy and safety of radioimmunotherapy (RIT) with Zevalin® in nine patients with recurrent follicular lymphoma (FL) who were treated in a consolidation setting aft...

    Authors: Francesco Pisani, Carlo Ludovico Maini, Rosa Sciuto, Laura Dessanti, Mariella D'Andrea, Daniela Assisi and Maria Concetta Petti
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:16
  19. This study aimed to investigate the molecular structural relationship between cell adhesive molecule CD44 and Lewis y antigen, and determine the effects of Lewis y antigen on CD44-mediated adhesion and spreadi...

    Authors: Lili Gao, Limei Yan, Bei Lin, Jian Gao, Xiuyun Liang, Yanyan Wang, Juanjuan Liu, Shulan Zhang and Iwamori Masao
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:15
  20. Cyclooxygenase-2 (COX-2) has recently been considered to promote lymphangiogenesis by up-regulating vascular endothelial growth factor-C (VEGF-C) in breast and lung cancer. However, the impact of COX-2 on lymp...

    Authors: Hong-Feng Gou, Xin-Chuan Chen, Jiang Zhu, Ming Jiang, Yu Yang, Dan Cao and Mei Hou
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:14
  21. Streptococcus bovis (S. bovis) bacteria are associated with colorectal cancer and adenoma. S. bovis is currently named S. gallolyticus. 25 to 80% of patients with S. bovis/gallolyticus bacteremia have concomitant...

    Authors: Ahmed S Abdulamir, Rand R Hafidh and Fatimah Abu Bakar
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:11
  22. To evaluate the therapeutic strategies commonly employed in the clinic for the management of brain metastases (BMs) and to correlate disease outcome with type of treatment and therapeutic resources available a...

    Authors: Alessandra Fabi, Alessandra Felici, Giulio Metro, Alessandra Mirri, Emilio Bria, Stefano Telera, Luca Moscetti, Michelangelo Russillo, Gaetano Lanzetta, Giovanni Mansueto, Andrea Pace, Marta Maschio, Antonello Vidiri, Isabella Sperduti, Francesco Cognetti and Carmine M Carapella
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:10
  23. Stem cells are a relevant source of information about cellular differentiation, molecular processes and tissue homeostasis, but also one of the most putative biological tools to treat degenerative diseases. Th...

    Authors: Daniele Lodi, Tommaso Iannitti and Beniamino Palmieri
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:9
  24. Hedgehog (Hh) signaling pathway is involved in regulation of many tissues development and oncogenesis. Recently, Hh signaling has been identified as a required functional pathway for leukemia stem cells(LSCs),...

    Authors: Bing Long, Huanling Zhu, Cuixia Zhu, Ting Liu and Wentong Meng
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:8
  25. To implement a new cost efficacy internal Service for blood component irradiation, we carried out specific procedures and quality assurance reports using the linear accelerators (LINACs) of the Regina Elena In...

    Authors: Paola Pinnarò, Antonella Soriani, Daniela D'Alessio, Carolina Giordano, Maria Laura Foddai, Valentina Pinzi and Lidia Strigari
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:7
  26. Vascular endothelial growth factor (VEGF) expression is up-regulated via a cyclooxygenase-2 (COX-2)-dependent mechanism in non-small cell lung cancer (NSCLC), but the specific signaling pathway involved is unc...

    Authors: Honghe Luo, Zhenguang Chen, Hui Jin, Mei Zhuang, Tao Wang, Chunhua Su, Yiyan Lei, Jianyong Zou and Beilong Zhong
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:6
  27. SULF1 (sulfatase 1) selectively removes the 6-O-sulphate group from heparan sulfate, changing the binding sites for extracellular growth factors. SULF1 expression has been reported to be decreased in various canc...

    Authors: Chan H Han, Yu-Jing Huang, Karen H Lu, Zhensheng Liu, Gordon B Mills, Qingyi Wei and Li-E Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:5
  28. The best method to deliver intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis from ovarian cancer is not well defined. The aim of this study was to assess the ability of hyperthermia and adrenali...

    Authors: Olivier Facy, François Radais, Sylvain Ladoire, Delphine Delroeux, Hervé Tixier, François Ghiringhelli, Patrick Rat, Bruno Chauffert and Pablo Ortega-Deballon
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:4
  29. An increasing body of evidence now implicates acetaldehyde as a major underlying factor for the carcinogenicity of alcoholic beverages and especially for oesophageal and oral cancer. Acetaldehyde associated wi...

    Authors: Dirk W Lachenmeier and Yulia B Monakhova
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:3
  30. Cancer-testis antigens (CTAs) are suitable targets for cancer-specific immunotherapy. The aim of the study is to investigate the expression of CTAs in intrahepatic cholagiocarcinoma (IHCC) and evaluate their p...

    Authors: Jin-xue Zhou, Yin Li, Sun-xiao Chen and An-mei Deng
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:2
  31. Telomerase plays an important role in cell proliferation and carcinogenesis and is believed to be a good target for anti-cancer drugs. Elimination of template function of telomerase RNA may repress the telomer...

    Authors: Yingying Lu, Junchao Gu, Dachuan Jin, Yanjing Gao and Mengbiao Yuan
    Citation: Journal of Experimental & Clinical Cancer Research 2011 30:1
  32. Anticancer activities of several substituted naphthalimides (1H-benz[de]isoquinoline-1,3-diones) are well documented. Some of them have undergone Phase I-II clinical trials. Presently a series of ten N-(hydrox...

    Authors: Asama Mukherjee, Sushanta Dutta, Muthiah Shanmugavel, Dilip M Mondhe, Parduman R Sharma, Shashank K Singh, Ajit K Saxena and Utpal Sanyal
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:175
  33. This study aimed to determine the miRNA profile in breast cancer stem cells (BCSCs) and to explore the functions of characteristic BCSC miRNAs.

    Authors: Jian-guo Sun, Rong-xia Liao, Jun Qiu, Jun-yu Jin, Xin-xin Wang, Yu-zhong Duan, Fang-lin Chen, Ping Hao, Qi-chao Xie, Zhi-xin Wang, De-zhi Li, Zheng-tang Chen and Shao-xiang Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:174
  34. Primary and secondary drug resistance to imatinib and sunitinib in patients with gastrointestinal stromal tumors (GISTs) has led to a pressing need for new therapeutic strategies such as drug combinations. Mos...

    Authors: Maria Abbondanza Pantaleo, Giordano Nicoletti, Cristina Nanni, Chiara Gnocchi, Lorena Landuzzi, Carmelo Quarta, Stefano Boschi, Margherita Nannini, Monica Di Battista, Paolo Castellucci, Stefano Fanti, Pier Luigi Lollini, Elena Bellan, Mauro Castelli, Domenico Rubello and Guido Biasco
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:173
  35. Specific gene expression is tightly regulated by various transcription factors. Osteopontin (OPN) is a phosphoprotein that mediates hepatocellular carcinoma (HCC) progression and metastasis. However, the mecha...

    Authors: Rong-Xin Chen, Yun-Hong Xia, Tong-Chun Xue and Sheng-Long Ye
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:172
  36. The present study was undertaken to relate the co-expression of prostate-associated antigens, PSMA and PSA, with the degree of vascularization in normal and pathologic (hyperplasia and cancer) prostate tissues...

    Authors: Awatef Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Ahmed Banasr, Nawfel Ben Rais, Latifa Ouertani, Yassin Nouira, Ali Horchani and Ridha Oueslati
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:171
  37. The purpose of the study was to explore the anti-tumor effect of ultrasound -targeted microbubble destruction mediated herpes simplex virus thymidine kinase (HSV-TK) suicide gene system on mice hepatoma.

    Authors: Shiji Zhou, Shengwei Li, Zuojin Liu, Yong Tang, Zhigang Wang, Jianping Gong and Changan Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:170
  38. The existence of cancer stem cells in hepatocellular carcinoma (HCC) has been verified by characterizing side population (SP) cells based on efflux of Hoechst 33342 dye from stem cells. Recent advances in micr...

    Authors: Ren Li, Niansong Qian, Kaishan Tao, Nan You, Xinchuan Wang and Kefeng Dou
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:169
  39. The Open Archive Initiative (OAI) refers to a movement started around the '90s to guarantee free access to scientific information by removing the barriers to research results, especially those related to the e...

    Authors: Elisabetta Poltronieri, Ivana Truccolo, Corrado Di Benedetto, Mauro Castelli, Mauro Mazzocut and Gaetana Cognetti
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:168
  40. ChromograninA in prostate carcinoma (PC) indicate NE differentiation. This tumour is more aggressive and resistant to hormone therapy.

    Authors: Marialuisa Appetecchia, Aurela Meçule, Giuseppe Pasimeni, Concetta V Iannucci, Piero De Carli, Roberto Baldelli, Agnese Barnabei, Giovanni Cigliana, Isabella Sperduti and Michele Gallucci
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:166
  41. Imatinib, a selective tyrosine kinase inhibitor, has been used as a standard first-line therapy for irresectable and metastasized gastrointestinal stromal tumor (GIST) patients. Unfortunately, most patients re...

    Authors: Hoang Thanh Chi, Bui Thi Kim Ly, Takahiro Taguchi, Toshiki Watanabe and Yuko Sato
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:165
  42. More data about TACE and pTACE seem necessary to better define the global treatment strategy for HCC. Aim of our analysis was to evaluate the role of TACE, either with lipiodol (traditional) or drug-eluting mi...

    Authors: Mario Scartozzi, Gianluca Svegliati Baroni, Luca Faloppi, Marzia Di Pietro Paolo, Chiara Pierantoni, Roberto Candelari, Rossana Berardi, Stefania Antognoli, Cinzia Mincarelli, Andrea Risaliti, Cristina Marmorale, Ettore Antico, Antonio Benedetti and Stefano Cascinu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:164
  43. In spite of its establishment from the peripheral blood of a case with acute myeloid leukemia (AML)-M1, HPB-AML-I shows plastic adherence with spindle-like morphology. In addition, lipid droplets can be induce...

    Authors: Bambang Ardianto, Takeshi Sugimoto, Seiji Kawano, Shimpei Kasagi, Siti NA Jauharoh, Chiyo Kurimoto, Eiji Tatsumi, Keiko Morikawa, Shunichi Kumagai and Yoshitake Hayashi
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:163
  44. Somatostatin prevents cell proliferation by inducing apoptosis. Downregulation of the XAF1 transcript may occur during the development of prostate cancer. It is interesting to evaluate the potential regulatory ef...

    Authors: Zhaoquan Xing, Zunlin Zhou, Rong Yu, Shuling Li, Chunde Li, Sten Nilsson and Zhaoxu Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:162

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions